COVID-19: CDRH Staff Leaves Door Open For Some LDT Safety Oversight
Executive Summary
US FDA staff spoke on HHS’s new laboratory developed test edict, as well as ongoing concerns around new test types and reviewer responsiveness in a recent virtual town hall.